<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D9D173EA-C6E0-451C-8438-F29BF99FF5D3"><gtr:id>D9D173EA-C6E0-451C-8438-F29BF99FF5D3</gtr:id><gtr:name>Macquarie University</gtr:name><gtr:address><gtr:line1>Macquarie University</gtr:line1><gtr:line4>North Ryde</gtr:line4><gtr:postCode>NSW 2109</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9B1866C-EE3E-4D81-A83C-118745E9433E"><gtr:id>A9B1866C-EE3E-4D81-A83C-118745E9433E</gtr:id><gtr:name>Goldsmiths College</gtr:name><gtr:address><gtr:line1>Lewisham Way</gtr:line1><gtr:line2>New Cross</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE14 6NW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Social Genetic and Dev Psychiatry Centre</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D9D173EA-C6E0-451C-8438-F29BF99FF5D3"><gtr:id>D9D173EA-C6E0-451C-8438-F29BF99FF5D3</gtr:id><gtr:name>Macquarie University</gtr:name><gtr:address><gtr:line1>Macquarie University</gtr:line1><gtr:line4>North Ryde</gtr:line4><gtr:postCode>NSW 2109</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9B1866C-EE3E-4D81-A83C-118745E9433E"><gtr:id>A9B1866C-EE3E-4D81-A83C-118745E9433E</gtr:id><gtr:name>Goldsmiths College</gtr:name><gtr:address><gtr:line1>Lewisham Way</gtr:line1><gtr:line2>New Cross</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE14 6NW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B8DB9AED-373D-4746-AE31-2BA10C7CF1AF"><gtr:id>B8DB9AED-373D-4746-AE31-2BA10C7CF1AF</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Keers</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK021281%2F1"><gtr:id>272BC1A0-F70A-4DA9-909B-84926602E60A</gtr:id><gtr:title>Translating gene-environment interaction from aetiology to personalised medicine for anxiety and depression.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/K021281/1</gtr:grantReference><gtr:abstractText>Anxiety and depression are the most common of all mental illnesses affecting as many as one in five people at some point in their lives. They are also amongst the earliest to emerge, with the majority of adult cases of both disorders beginning in childhood or adolescence. Anxiety and depression are extremely costly for afflicted individuals and society as a whole resulting in reduced over-all educational level, increased usage of sick leave and benefits and increased risk of substance dependence and suicide.

Cognitive Behavioural Therapy (CBT) has been shown to be a safe, effective treatment for both depression and anxiety in children and adults. Nevertheless, at least two in five patients do not respond to CBT and may need to switch to a different treatment such as medication. Finding predictors of response is extremely important as it will allow doctors to pick the right treatment for the right person from the start, cutting costs and speeding up their recovery.

Recent research suggests that 'plasticity' genes might make some individuals more sensitive to their environment than others. These 'plasticity' genes may therefore be important predictors of response to CBT. Dr Robert Keers will test this proposition at the institute of Psychiatry in London and Emory University, Atlanta. Dr Keers will attempt to identify new plasticity genes using a novel twin based method and then test these genes as predictors of response to CBT in patients with anxiety and depression.</gtr:abstractText><gtr:technicalSummary>Aim: To investigate whether genes that moderate the effects of the environment on the development of depression and anxiety may also predict response to psychological treatment.

Objectives
1. Examine the extent to which genes moderate the effects of the environment on anxiety and depression.
2. Identify the genetic variants involved.
3. Test these variants as predictors of response to CBT.

Methods
Objective 1
Sample: 10,301 twin and sibling pairs.
Analyses: An established quantitative-genetic model to test for gene-environment interaction will be used to examine the extent to which genes moderate the effects of positive and negative environments on depression and anxiety.

Objective 2
Sample: 1,183 monozygotic twin pairs.
Analyses: A novel extension of the monozygotic twin differences design, which examines within-pair discordance as a function of genotype, will be used to identify genetic variants that moderate the effects of the environment on depression and anxiety. 

Objective 3
Sample: 2,000 anxious children treated with CBT and 400 depressed adults treated with either CBT or medication.
Analyses: Genotypes detected in Objective 2 will be tested as predictors of change and remission of symptoms.

Scientific and medical opportunities: The results of this research may have far reaching implications for understanding the aetiology of depression and anxiety and their prevention and treatment. Variants suggestive of increased environmental sensitivity may enable targeted interventions for individuals at a high-risk of developing these disorders. These same genotypes may also be used to select the most effective treatment for a given patient. Given their prevalence, and their substantial social and economic costs, advancing the prevention and treatment of depression and anxiety would lead to improved mental health and well-being for a significant proportion of the population and ultimately benefit society as a whole.</gtr:technicalSummary><gtr:potentialImpactText>Who will benefit? 
The results from this program of research may have far reaching implications for improving the prevention and treatment of affective disorders. Given the prevalence of these disorders, these improvements will therefore have a profound impact on the mental health and well-being of a large proportion of the population. The social and economic cost of anxiety and depression means that ultimately society as a whole could benefit from this research.

How will they benefit? 
This research will feed into three key areas aimed at reducing mental health problems in the population: Targeted intervention, personalised medicine and the development of novel treatments. 

1) Targeted intervention: A growing body of research suggests that early intervention with cognitive behavioural prevention can limit the onset of emotional disorders in children. By identifying genetic variants suggestive of increased sensitivity to the environment or response to psychological treatments, the current research may allow for these prevention programmes to be targeted at those at a high-risk of anxiety or depression and those who will reap the most benefit from these preventative measures.

2) Personalised medicine: Cognitive Behavioural Therapy (CBT) is currently being rolled out in the UK as the first line treatment for depression and anxiety in adults and children as part of the Improving Access to Therapy (IAPT) initiative. However, at least two in five individuals do not respond to CBT and may require additional or alternative treatments. Genetic predictors of treatment response would allow for a personalised approach to CBT. This means that clinicians will be able to select the most effective treatment for a given patient prior right from the start, cutting costs and speeding up recovery times.

3) New treatments: Current treatment options for anxiety and depression are ineffective for a substantial proportion of sufferers. By identifying genetic factors involved in the aetiology of depression and anxiety, natural resilience to these disorders and response to treatment the current study may provide novel targets for pharmacological and non-pharmacological treatments.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-07-22</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>270776</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Marianus van Ijzendoorn</gtr:description><gtr:id>7E3724DA-3E1E-4C5F-AF88-BB4223DD533C</gtr:id><gtr:impact>The collaboration was multidisciplinary involving statistical genetics (us) and a leading child development psychologist. The collaboration has resulted in a draft manuscript</gtr:impact><gtr:outcomeId>58c511ea3e6255.76832753-1</gtr:outcomeId><gtr:partnerContribution>Our partners collected the primary data and provided funding for the data collection, genotyping and analyses. They are leading the analyses with support from us.</gtr:partnerContribution><gtr:piContribution>Professor Van Ijzendoorn approached us about using our polygenic environmental sensitivity score to investigate genetic moderation of environmental influences in the large and well characterized Generation R study. We provided them with the data and are supporting their analyses and interpretation of the findings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute of Psychiatry</gtr:department><gtr:description>Dr Elisabeth Binder</gtr:description><gtr:id>272086A1-45E5-489A-91B7-D9D84B66899C</gtr:id><gtr:impact>This work is due to commence following the completion of the first two objectives of my MRC population health science fellowship. It aims to result in at least one high impact publication.</gtr:impact><gtr:outcomeId>FeW8gdBr9Yj-1</gtr:outcomeId><gtr:partnerContribution>Dr Binder will provide access to data and biological samples from the PReDICT study. She will also provide specialist training in the design, implementation and analyses of complex treatment response trials and in integrated analyses of genetic data with longitudinally collected biomarkers.</gtr:partnerContribution><gtr:piContribution>This collaboration is essential to complete the final objective of my MRC population health science fellowship: to test differential susceptibility genes as predictors of response to Cognitive behavioural therapy (CBT)

I aim to replicate my findings from an earlier analyses of CBT response in children by genotyping selected markers in PReDICT, a sample of adults with major depression undergoing treatment with either medication or Cognitive Behavioral Therapy. This work will allow my findings to be extended from child to adult populations and from anxiety to depression. Moreover, the comparative design of the PReDICT study will allow me to test if the variants he detects predict differential response to CBT over established antidepressants.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Elaine Fox - Cogbias project</gtr:description><gtr:id>76EA172D-DFB4-4288-ADDA-C514553597F5</gtr:id><gtr:impact>We are still in the early stages of data cleaning on this project but have drafted a protocol paper and are in the process of registering our research questions and hypothesis prior to analyses.</gtr:impact><gtr:outcomeId>58c51a5d8a1b07.12370111-1</gtr:outcomeId><gtr:partnerContribution>Professor Fox conceptualised, designed and obtained funding for the study. Her team collected the data including biological samples for genotyping. The cogbias team bring expertise in cogntiive bias experiments in relation to depression and anxiety.</gtr:partnerContribution><gtr:piContribution>We have provided support on the genetic aspects of the CogBias project. We co-ordinated DNA extraction, genotyping and quality control of the subsequent data. We will provide continued support in the analysis of candidate gene data and will take the lead in several genome-wide projects using the data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Social Genetic and Developmental Psychiatry Centre (SDGP)</gtr:department><gtr:description>Professor Thalia Eley</gtr:description><gtr:id>DB60E25D-60CA-4D3C-915D-B17D6FAFE518</gtr:id><gtr:impact>Analyses are underway. At least one high impact publication is planned for this project</gtr:impact><gtr:outcomeId>fifNreQiNoZ-1</gtr:outcomeId><gtr:partnerContribution>Professor Eley will provide access to data and biological samples from GxT. She will also provide training in the analyses and interpretation of therapygenetic data and in the design and implementation of therapygenetic studies</gtr:partnerContribution><gtr:piContribution>This collaboration is essential to the completion of objective 3 of my MRC population health science fellowship: Test differential susceptibility genes as predictors of response to cognitive behavioural therapy (CBT).

Using a sample of children with anxiety treated with CBT (the GxT sample), I will use linear and logistic mixed models to investigate the effects of variants identified in previous objectives of the fellowship as predictors of treatment response (change in anxiety severity) and remission respectively. The aggregate effects of these SNPs on response to treatment will be explored using a cumulative genetic score (CGS) approach. The effects of further variants with smaller effect sizes reaching nominal levels of significance (P&amp;lt;0.05) will be tested using meta-analytic and polygenic risk score approaches.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Goldsmiths, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Psychology</gtr:department><gtr:description>Alice Gregory - SLEEPIO study</gtr:description><gtr:id>B85744D6-ABA3-409C-A4BB-27EB393508AC</gtr:id><gtr:impact>The study is multidisciplinary involving a behavior geneticist (Dr Gregory) and statistical geneticist (myself). A protocol paper has been drafted and will be submitted for publication shortly.</gtr:impact><gtr:outcomeId>58c513e2ab4b05.59789937-1</gtr:outcomeId><gtr:partnerContribution>Dr Gregory conceptualized the study and the initial study design. She also sought ethical approval and funding for the project.</gtr:partnerContribution><gtr:piContribution>Dr Gregory consulted me on setting up a study to explore genetic predictors of response to the CBT app for sleep problems (SLEEPIO). I consulted on the design of the study, recruitment of participants and the planned analyses. I will be responsible for the analyses of the genetic data, using the polygenic score generated as part of my MRC fellowship to predict response to SLEEPIO.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Michael Pluess</gtr:description><gtr:id>3A4910E0-9C35-4460-A9E3-F88368A79E51</gtr:id><gtr:impact>We have coauthored a paper together on gene-environment interaction across the life-course. The paper is currently under review at Development and Psychopathology. We are also coauthoring a review article on gene-environment interaction in mental illness which will be submitted at the end of the month.</gtr:impact><gtr:outcomeId>58c5155adc7865.41235079-1</gtr:outcomeId><gtr:partnerContribution>Michael brings expertise in child psychology and gene environment interaction.</gtr:partnerContribution><gtr:piContribution>I have collaborated with Michael on several projects and co-supervise two PhD students. While Michael has expertise in developmental psychology and gene-environment interaction, I bring expertise in statistical genetics. Most of our work includes investigating gene-environment interaction using candidate gene and whole genome approaches.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Macquarie University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Jennifer Hudson</gtr:description><gtr:id>1A07D78A-752A-4380-8D07-D01C11B18BA9</gtr:id><gtr:impact>This is a multi-disciplinary collaboration combining expertise from child psychiatry and psychology with statistical genetics.

I have collaborated with Professor Hudson on a number of projects resulting several high impact publications. 
 
10.1002/ajmg.b.32467 
10.1192/bjp.bp.115.168229
10.1159/000444023
10.1002/da.22430
10.1192/bjp.bp.114.154997
10.1016/j.jaac.2015.03.018

We have several further studies planned including a grant submitted to the ARC to examine whether polygenic score I developed as part of the MRC fellowship can be used to stratify patients to low, medium and high intensity CBT. This will be the first study to explore whether a genetic score can be used to personalise CBT and if successful will provide significant impact for the findings from my fellowship.</gtr:impact><gtr:outcomeId>58c518a88a2cf6.37356818-1</gtr:outcomeId><gtr:partnerContribution>Jen brings expertise in child psychology and psychiatry and clinical trial data.</gtr:partnerContribution><gtr:piContribution>I bring expertise in statistical genetics and analyses of longitudinal treatment response data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Social Genetic and Developmental Psychiatry Centre (SDGP)</gtr:department><gtr:description>Professor Robert Plomin</gtr:description><gtr:id>38D6A83E-EF9A-4F91-AD32-DFD9253A2117</gtr:id><gtr:impact>Analyses for both objectives is currently underway. At least two high impact papers are planned from this research</gtr:impact><gtr:outcomeId>ArZuynXngdF-1</gtr:outcomeId><gtr:partnerContribution>Professor Plomin is the principal investigator of the TEDS Study and a leader in the field of behavioural genetics and gene-environment interplay. 

He has provided access to data and support in the analysis, interpretation of my findings in both of the above Objectives.</gtr:partnerContribution><gtr:piContribution>This collaboration, which centres on data from the Twins Early Development Study (TEDS), is essential for the completion of the first two objectives of my MRC population health science fellowship. 

Objective 1: Examine the extent to which genetic factors moderate the effects of positive and negative environments on the development of anxiety or depression. An established quantitative-genetic model to test for gene-environment interaction will be used to examine the extent to which genes moderate the effects of positive and negative environments on depression and anxiety.

Objective 2: Identify new differential susceptibility genes. A novel extension of the monozygotic twin differences design, which examines within-pair discordance as a function of genotype, will be used to identify genetic variants that moderate the effects of the environment on depression and anxiety.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pint of Science - Unravelling the nature and nurture of mental ilnesses</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A9E0B28B-E6A2-46D0-A7CF-73A0843872BC</gtr:id><gtr:impact>I gave a 30 minute talk at The Pint of Science festival. These talks aim to deliver interesting and relevant information on the latest science research in an accessible format to the public across bars and pubs. The talk provoked a lot of discussion and interest in the causes of mental illness. The organizers have invited me back to update on my work next year.</gtr:impact><gtr:outcomeId>58c50e4f4a97e7.39091110</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.com/about/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biological Interfaces with Social Science- Three Day Summer Workshop at the MRC SGDP, Institute of Psychiatry, KCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>21DE5263-25BB-4B31-AFD2-DED501332FCF</gtr:id><gtr:impact>The social world impacts on a range of internal biological processes (e.g., regulation of hormones, brain development and activity, functioning of genes) and in turn biology can influence responses to the environment (e.g., genetic sensitivity to social stressors). However, social scientists often have little, if any, biological training and thus there is a need to equip them with insights into the biological world to enable them to appreciate the wider context within which the social factors they study are operating.
I gave a talk on therapygenetics to social science students as part of a 3-day workshop which aimed to provide students with important insights into the theoretical and practical aspects of conducting research across the social-biological interface.

Following this talk I was approached by several post-graduate students who were interested in gaining experience in our research group with an aim to incorporate a genetic element in their research.</gtr:impact><gtr:outcomeId>5460f4a7ca19c0.05065922</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D951F078-CF2C-4178-ADC4-41CE9F62D545</gtr:id><gtr:title>Childhood quality influences genetic sensitivity to environmental influences across adulthood: A life-course Gene &amp;times; Environment interaction study.</gtr:title><gtr:parentPublicationTitle>Development and psychopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67a2bb6306ba3b6802588c81c283f74f"><gtr:id>67a2bb6306ba3b6802588c81c283f74f</gtr:id><gtr:otherNames>Keers R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0954-5794</gtr:issn><gtr:outcomeId>5a86d7d2660b21.89018622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7D8922-CC3B-44B8-B916-F50E6AD56894</gtr:id><gtr:title>Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bdc076a47d54fe530e58d4a3dfeaf81"><gtr:id>9bdc076a47d54fe530e58d4a3dfeaf81</gtr:id><gtr:otherNames>Hodgson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>546230f184f9b4.96128290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B45B2800-7E6E-4311-B70C-5CFCBFB3B193</gtr:id><gtr:title>Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0061725cba620664df0b93abfff78c48"><gtr:id>0061725cba620664df0b93abfff78c48</gtr:id><gtr:otherNames>Roberts S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>5a86d7d3af9f56.71498319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C0D0C5E-52BA-4625-A79D-532959255108</gtr:id><gtr:title>HPA AXIS RELATED GENES AND RESPONSE TO PSYCHOLOGICAL THERAPIES: GENETICS AND EPIGENETICS.</gtr:title><gtr:parentPublicationTitle>Depression and anxiety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0061725cba620664df0b93abfff78c48"><gtr:id>0061725cba620664df0b93abfff78c48</gtr:id><gtr:otherNames>Roberts S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1091-4269</gtr:issn><gtr:outcomeId>56b33b09dd4ad9.13382354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4AE68C1-D58D-49DE-A14D-2D63F8F88D07</gtr:id><gtr:title>Gene-environment interaction and psychiatric disorders: Review and future directions.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0ed59e9be9317b0add0b86b63645800"><gtr:id>d0ed59e9be9317b0add0b86b63645800</gtr:id><gtr:otherNames>Assary E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>5a86d7d3819262.65830094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9122832B-2807-47A9-889E-84496D9B3408</gtr:id><gtr:title>Sleep Treatment Outcome Predictors (STOP) Pilot Study: a protocol for a randomised controlled trial examining predictors of change of insomnia symptoms and associated traits following cognitive-behavioural therapy for insomnia in an unselected sample.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4f329251b1440ecb782aa9cad2ebfd"><gtr:id>bd4f329251b1440ecb782aa9cad2ebfd</gtr:id><gtr:otherNames>Denis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a86d7d2db2ea0.81599312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E0005A1-419B-4D1E-9B32-1448146E1CFE</gtr:id><gtr:title>Clinical Predictors of Response to Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders: The Genes for Treatment (GxT) Study.</gtr:title><gtr:parentPublicationTitle>Journal of the American Academy of Child and Adolescent Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e867f1c0ffc25b42641dd830d61a5d1"><gtr:id>2e867f1c0ffc25b42641dd830d61a5d1</gtr:id><gtr:otherNames>Hudson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0890-8567</gtr:issn><gtr:outcomeId>5675e518b0c77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0323D961-B655-41DE-A8A5-5B0F6AD6D0E6</gtr:id><gtr:title>Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00d0594d77ad2032d3b2d0231ab790e0"><gtr:id>00d0594d77ad2032d3b2d0231ab790e0</gtr:id><gtr:otherNames>Lester KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>585d315ac373f8.24643671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1202C82-4775-4B7D-8C83-27623C232054</gtr:id><gtr:title>Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00d0594d77ad2032d3b2d0231ab790e0"><gtr:id>00d0594d77ad2032d3b2d0231ab790e0</gtr:id><gtr:otherNames>Lester KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>56b33b099ab3d9.46222213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>956A0B70-E764-40DB-85CB-CA0C9E67FE9A</gtr:id><gtr:title>Paranoid Ideation and Violence: Meta-analysis of Individual Subject Data of 7 Population Surveys.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9397ae248d7a3e7da4afce089ac4be99"><gtr:id>9397ae248d7a3e7da4afce089ac4be99</gtr:id><gtr:otherNames>Coid JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>58c50f74484086.80230728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F59E4AF-1B9E-4DA5-A0DA-C297B5FE6BA4</gtr:id><gtr:title>The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d54f8c9daf0d599fe0205c2444a74a"><gtr:id>45d54f8c9daf0d599fe0205c2444a74a</gtr:id><gtr:otherNames>Malki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>pm_540e198e198d7505e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A3B5A00-6A19-4E0D-A5D5-089E284617C0</gtr:id><gtr:title>Childhood maltreatment and violence: mediation through psychiatric morbidity.</gtr:title><gtr:parentPublicationTitle>Child abuse &amp; neglect</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8477aff5ae576d62492bdeb1a7f56818"><gtr:id>8477aff5ae576d62492bdeb1a7f56818</gtr:id><gtr:otherNames>Gonz?lez RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0145-2134</gtr:issn><gtr:outcomeId>56b33b096eb584.41382267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6406AB6-64D8-4A56-BD58-F094D3EC248B</gtr:id><gtr:title>The CogBIAS longitudinal study protocol: cognitive and genetic factors influencing psychological functioning in adolescence.</gtr:title><gtr:parentPublicationTitle>BMC psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdecf5cde19797c22e9c8623e4fd7eb"><gtr:id>8cdecf5cde19797c22e9c8623e4fd7eb</gtr:id><gtr:otherNames>Booth C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-7283</gtr:issn><gtr:outcomeId>5a86d7d222a2a0.49155861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA9B2DC2-9F79-4A47-A35B-21E04339EC88</gtr:id><gtr:title>Genome-wide association study of response to cognitive-behavioural therapy in children with anxiety disorders.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b252d9cd9b61826bfe5648a3d52d7171"><gtr:id>b252d9cd9b61826bfe5648a3d52d7171</gtr:id><gtr:otherNames>Coleman JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>56b33f353d53b5.79631429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>709F989B-642B-4829-A757-D9BA7BBA3290</gtr:id><gtr:title>Separate and combined effects of genetic variants and pre-treatment whole blood gene expression on response to exposure-based cognitive behavioural therapy for anxiety disorders.</gtr:title><gtr:parentPublicationTitle>The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b252d9cd9b61826bfe5648a3d52d7171"><gtr:id>b252d9cd9b61826bfe5648a3d52d7171</gtr:id><gtr:otherNames>Coleman JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1562-2975</gtr:issn><gtr:outcomeId>58c50f741705f5.74258831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4E9EA9B-160D-4BB6-8DDE-C128A25D8B50</gtr:id><gtr:title>Genome-wide association study of facial emotion recognition in children and association with polygenic risk for mental health disorders.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567e071f1f305ee23c51cdbeffb605da"><gtr:id>567e071f1f305ee23c51cdbeffb605da</gtr:id><gtr:otherNames>Coleman JRI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>5a86d7d299f331.18931762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C7A0B37-EED3-4DB9-8ABE-AD4D664B0542</gtr:id><gtr:title>A Genome-Wide Test of the Differential Susceptibility Hypothesis Reveals a Genetic Predictor of Differential Response to Psychological Treatments for Child Anxiety Disorders.</gtr:title><gtr:parentPublicationTitle>Psychotherapy and psychosomatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67a2bb6306ba3b6802588c81c283f74f"><gtr:id>67a2bb6306ba3b6802588c81c283f74f</gtr:id><gtr:otherNames>Keers R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-3190</gtr:issn><gtr:outcomeId>56b33e454bb1e0.72007235</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K021281/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>